DK434087A - Applikationsformer af alfa-interferoner - Google Patents

Applikationsformer af alfa-interferoner

Info

Publication number
DK434087A
DK434087A DK434087A DK434087A DK434087A DK 434087 A DK434087 A DK 434087A DK 434087 A DK434087 A DK 434087A DK 434087 A DK434087 A DK 434087A DK 434087 A DK434087 A DK 434087A
Authority
DK
Denmark
Prior art keywords
application forms
alfa interferons
alfa
interferons
forms
Prior art date
Application number
DK434087A
Other languages
English (en)
Other versions
DK434087D0 (da
Inventor
Robert Becker
Bernd Kruss
Leonhard Schilk
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK434087D0 publication Critical patent/DK434087D0/da
Publication of DK434087A publication Critical patent/DK434087A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK434087A 1986-08-21 1987-08-20 Applikationsformer af alfa-interferoner DK434087A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863628468 DE3628468A1 (de) 1986-08-21 1986-08-21 Neue applikationsformen fuer (alpha)-interferone

Publications (2)

Publication Number Publication Date
DK434087D0 DK434087D0 (da) 1987-08-20
DK434087A true DK434087A (da) 1988-02-22

Family

ID=6307914

Family Applications (1)

Application Number Title Priority Date Filing Date
DK434087A DK434087A (da) 1986-08-21 1987-08-20 Applikationsformer af alfa-interferoner

Country Status (14)

Country Link
US (1) US4824674A (da)
EP (1) EP0258683A3 (da)
JP (1) JPS6351338A (da)
KR (1) KR880002541A (da)
AU (1) AU590958B2 (da)
CA (1) CA1313131C (da)
DE (1) DE3628468A1 (da)
DK (1) DK434087A (da)
FI (1) FI89007C (da)
IL (1) IL83585A0 (da)
NO (1) NO873513L (da)
NZ (1) NZ221497A (da)
PT (1) PT85561B (da)
ZA (1) ZA876166B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
DE3826055A1 (de) * 1988-07-30 1990-02-01 Boehringer Mannheim Gmbh Mit reagenz abloesbar impraegnierte traegermatrix
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
CA2120950A1 (en) * 1991-10-11 1993-04-15 Mark C. Gillies Treating ophthalmic fibrosis using interferon-alpha
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
DE19549506C2 (de) * 1995-03-07 1998-07-30 Richard Prof Dr Sueverkruep Darreichungsform zur äußerlichen Applikation und Verfahren zur Herstellung derselben
ES2213910T3 (es) * 1998-06-22 2004-09-01 Unihart Corporation Parche adhesivo de liberacion controlada de interferon natural.
US20030206945A1 (en) * 2000-12-20 2003-11-06 Giulio Tarro Sticking plaster for controlled release of natural interferon
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
EP1455692B1 (en) 2001-12-04 2010-02-17 Active Implants Corporation Cushion bearing implants for load bearing applications
KR102116202B1 (ko) 2010-11-08 2020-05-28 제넨테크, 인크. 피하 투여용 항―ｉｌ―6 수용체 항체
US20160114048A1 (en) * 2013-05-16 2016-04-28 Universiteit Antwerpen Thermolabile drug release formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1055896A (en) * 1963-12-10 1967-01-18 Glaxo Lab Ltd Silica adsorbents in interferon purification and/or concentration
DE2017373A1 (de) * 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
SE374272B (da) * 1973-08-31 1975-03-03 D A Safwat
US3932617A (en) * 1974-05-24 1976-01-13 The Upjohn Company Interferon induction
US4363634A (en) * 1980-07-18 1982-12-14 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4357142A (en) * 1980-07-18 1982-11-02 Akzona Incorporated Glass support coated with synthetic polymer for bioprocess
US4414147A (en) * 1981-04-17 1983-11-08 Massachusetts Institute Of Technology Methods of decreasing the hydrophobicity of fibroblast and other interferons
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
JPS5892621A (ja) * 1981-11-28 1983-06-02 Sunstar Inc インタ−フエロンを安定に配合した製剤
DE3262575D1 (en) * 1981-12-23 1985-04-18 Schering Corp Stabilised interferon formulations and their preparation
JPS59181224A (ja) * 1983-03-29 1984-10-15 Sumitomo Chem Co Ltd 安定なインタ−フエロン製剤の製法
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
DE3513288A1 (de) * 1985-04-13 1986-10-23 Dr. Karl Thomae Gmbh, 7950 Biberach Verfahren und vorrichtung zur beaufschlagung von augenstaebchen mit wirkstoffloesungen oder -suspensionen

Also Published As

Publication number Publication date
EP0258683A2 (de) 1988-03-09
US4824674A (en) 1989-04-25
DK434087D0 (da) 1987-08-20
JPS6351338A (ja) 1988-03-04
NO873513D0 (no) 1987-08-20
ZA876166B (en) 1989-05-30
NO873513L (no) 1988-02-22
CA1313131C (en) 1993-01-26
AU590958B2 (en) 1989-11-23
FI89007C (fi) 1993-08-10
FI873593A0 (fi) 1987-08-20
PT85561A (de) 1987-09-01
FI89007B (fi) 1993-04-30
KR880002541A (ko) 1988-05-09
FI873593A (fi) 1988-02-22
NZ221497A (en) 1990-04-26
PT85561B (pt) 1990-05-31
EP0258683A3 (de) 1988-09-07
AU7730787A (en) 1988-02-25
IL83585A0 (en) 1988-01-31
DE3628468A1 (de) 1988-03-03

Similar Documents

Publication Publication Date Title
DK207286D0 (da) Regulering af blodstroemning
DK376087D0 (da) Behandling af emulsioner
KR880701404A (ko) Cmos 전압 변환기
DK363887A (da) Anvendelse af bromcruptin
DK193588D0 (da) Anvendelser af dopaminagonister
DK348385D0 (da) Anvendelse af cyclosporiner
DK434087A (da) Applikationsformer af alfa-interferoner
DK427787D0 (da) Komponenter af plastmateriale
DK70486A (da) Fremstilling af polypeptider
DK38593A (da) Alkoxymethylethere af glyceroler
DK102389A (da) Anvendelse af interleukin
DK87888D0 (da) Terapeutisk anvendelse af tindijoddeuteroporfyrin
DK564886D0 (da) Fungicid anvendelse af tetrahydrobenzothienylurinstofderivater
DK420185A (da) Anvendelse af somatostatinanaloge
DK541487A (da) Sammenfoejning af materialer
DK237385A (da) Anvendelse af dihydroergotamin
DK185987A (da) Anvendelse af prostaglandiner
DK233487D0 (da) Oxygeneret perfluoreret perfusion af oejeaeblet
DK135387D0 (da) Fremstilling af proteiner
DK153045C (da) Sammenkobling af fortrinsvis langstrakte elementer
DK288086D0 (da) Frembringelse af billeder
DK167486D0 (da) Alfa-polyhalogenketoximer
NO2003006I2 (no) Dibotermin alfa
DK621088D0 (da) Theemballage af theposetypen
ES296589Y (es) Conjunto parcial de peluca

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment